ICNIRP and IEEE publish standards/guidelines for exposures to low-frequency electromagnetic fields and their associated in situ electric fields. Two methods are prescribed for spatially averaging the in situ electric field to evaluate compliance: averaging (1) over a 2 mm × 2 mm × 2 mm volume (ICNIRP) and (2) along a 5 mm linear segment of neural tissue (IEEE). However, detailed calculation procedures for these two schemes are not provided, particularly when the averaging volume/line straddles a tissue/air or tissue/tissue interface. This study proposes detailed schemes for implementing the volume-and lineaveraging in such cases, applying them to both a spherical model of layered tissues and a human anatomical model. To extend the applicability of the proposed averaging schemes to the voxels at the tissue boundaries, a parameter, p max , is introduced and defined as the maximum permissible percentage of air/other tissues in the averaging volume/line. For most inner-tissue voxels results show good agreement between the two averaging schemes, in general. Excluding skin, the relative differences between the two averaging schemes were less than 9% for the 99 th percentile in situ electric field, and these differences decrease as p max increases. Results indicate that around 20-30% inclusion of air or other tissues for volume averaging of internal tissues provides stable percentile values; less stability is observed across p max for linear averaging. Invoking the suggestion of ICNIRP (2010) that the averaging cube for skin ''may extend to subcutaneous tissue,'' ≥10% inclusion of air results in stable averaged induced electric fields.
I. INTRODUCTION
Limits for exposures to non-ionizing electromagnetic fields (EMF) from 0-300 GHz and contact currents from 0-110 MHz have been developed and published by the International Commission on Non-Ionizing Radiation Protection (ICNIRP) [1] , [2] and by the IEEE International Committee on Electromagnetic Safety (IEEE ICES) Technical Committee 95 [3] , [4] . For convenience this paper refers to these guidelines/standards as guidelines, the term used by ICNIRP, although IEEE applies the term standard.
ICNIRP defines the lower frequency range as <10 MHz, while the IEEE's is <5 MHz. In a general sense, both
The associate editor coordinating the review of this manuscript and approving it for publication was Flavia Grassi. aim to protect against magnetic-field-coupled stimulation of excitable tissue both in the central nervous system (CNS) and peripherally. Despite this mutual similarity, their specific approaches and specific quantitative limits differ on a number of counts [5] - [7] . Both guidelines specify not-to-beexceeded in situ electric fields in target tissue for exposure to an external magnetic field. ICNIRP calls the in situ limit the basic restriction (BR), and IEEE's equivalent term is the dosimetric reference limit (DRL). The limits established for environmental exposuresreference levels (RL) for ICNIRP and exposure reference levels (ERL) for IEEE -are derived such that compliance with them assures that the BR and DRL are not exceeded. ICNIRP's limits are classified either for the general public or for occupational exposure, with less conservative limits for the latter. IEEE divides exposure scenarios into either restricted or unrestricted environments, with the restricted environment denoting a location with the possibility of exceeding the unrestricted DRL.
ICNIRP addresses peripheral nerve stimulation (PNS) for frequencies >300 Hz for the general public and >400 Hz for occupational exposure; IEEE's ERLs protect against adverse PNS for frequencies >∼750 Hz for all environments. Below these frequencies the guidelines protect against adverse effects in the CNS. ICNIRP's guideline cites transient effects on ''brain functions such as visual processing and motor co-ordination'' based on indirect evidence, with IEEE identifying ''synaptic activity alteration'' as the undesired effect. Clearly, given these differences, there is a ''grey-area'' frequency range (∼300-750 Hz) within which the target tissue for deriving RLs and ERLs transitions from CNS to peripheral nerve.
The criteria dose for evaluating BR compliance is defined by ICNIRP ''as a vector average of the electric field in a small contiguous tissue volume of 2 ×2×2 mm 3 . For a specific tissue, the 99 th percentile value of the electric field is the relevant value to be compared with the basic restriction.'' This approach was selected ''as a practical compromise, satisfying requirements for a sound biological basis and computational constraints.'' A ''small-volume'' approach would appear to be more appropriate for evaluating BR exceedances in the CNS, as complex networks of synaptic and dendritic connections occupy small volumes [8] , whereas PNS results from electric field gradients parallel to the axon.
For IEEE, ''the in situ electric field DRL applies to the rms electric field strength measured in the direction and location providing the maximum in situ electric field vector (vector magnitude) over a 5 mm linear distance.'' The latter does not specify a percentile because the underlying dosimetry is based on closed form solutions of uniform isotropic ellipsoidal induction models. The 5-mm IEEE criterion was derived from the length of exposed myelinated nerve in an in situ electric field needed to trigger an action potential [9] , and thus may not be ideally applicable to predicting altered synaptic activity in the CNS.
These discrepancies have been detailed by Reilly and Hirata in the context of the IEEE-ICES research agenda [5] , and several working groups have been established to resolve related issues [10] - [12] . Future revisions to the IEEE-ICES standard will more than likely adopt dosimetry with anatomically realistic models, and considerations of percentile in situ electric fields will then be necessary.
Many studies [13] - [25] have reported the relationship between the external magnetic field and the in situ electric field coupled into tissue, with other analyses comparing results among different laboratories [26] - [28] . Historically, the 99 th percentile value of the current density or in situ electric field was introduced to exclude computational artefacts [29] , [30] . In low-frequency dosimetry, artefacts may include i) segmentation error in an anatomical model, which may include the quality of medical images acquired in millimeter resolution [31] , ii) discretization error in modeling tissue with a finite grid resolution [32] , and iii) potential error in the computations themselves, which may also partly originate in discretization error [33] .
The 99 th percentile value of the in situ electric field is acceptable (and possibly conservative) when the magnetic field is uniform across a tissue situated within a confined volume (e.g., heart, liver, kidney) [29] , [30] . However, it may be inappropriate for localized exposure to distributed tissue (e.g., skin, fat, peripheral nerve), in which the 99 th percentile across the entire distributed tissue would produce underestimates of the relevant dose to the localized site [11] .
Several techniques have been proposed to avoid underestimation of dose for localized exposures [11] , [34] , and may be classified as pre-or post-processing. Examples include a conductivity-smoothing algorithm was introduced before the numerical calculation of in situ electric field [34] , and an outlier removal method based on the frequency distribution of the highest 1% electric field strengths was proposed in [11] . However, these techniques are not adequately resolved for cases in which the prescribed averaging dimensions cross a tissue/tissue or a tissue/air interface. Specifically, ICNIRP and IEEE specify that the averaging volume or linear segment should not extend beyond the targeted tissue surface. However, this can exclude voxels (or line segments) that include the tissue boundary. The objective of this paper is to use post-processing techniques to quantify the permissible maximum fraction of such voxels or line segments that can be included in a computation without introducing unacceptable artefact. The analyses compare the cubic and linear averaging schemes, and the influence of the adjacent tissue or air beyond the tissue boundary are investigated using a multi-layered sphere and a detailed anatomical human model, each with a range of spatial resolutions.
II. COMPUTATIONAL METHODS AND HUMAN MODEL A. ELECTROMAGNETIC ANALYSIS
At frequencies up to ∼10 MHz, the human body is assumed to not perturb the external magnetic field [35] . Also, by ignoring propagation, capacitive, and inductive effects, Maxwell's equations are simplified with the quasi-static approximation [35] - [37] . The resulting electric scalar potentials for an external magnetic field are computed using the scalar-potential finite difference method:
where A 0 and σ denote the magnetic vector potential of the applied magnetic field and the tissue conductivity, respectively. In this study, the scalar potential is computed iteratively via the successive-over-relaxation and multigrid methods [38] . When (1) is solved, the in situ electric field E is calculated as: E = −∇ϕ − jωA 0 .
B. SPHERICAL/ANATOMICAL MODELS AND EXPOSURE SCENRIOS
A multi-layer sphere exposed to a uniform magnetic field is considered. As shown in Fig. 1 (a) , the multi-layer sphere The Japanese adult male model, TARO, is the anatomical model considered in this study. The original TARO model, developed at NICT, Japan, consisted of 2-mm voxels [39] , and a model with finer resolution was developed based on the algorithm proposed in [40] .
The transverse section of a TARO at eye height is shown in Fig. 1 (b) and Table 1 lists the tissues in the head with their assigned conductivities [41] . The dosimetry is conducted for TARO's exposure to a 50 Hz, 0.1 mT uniform magnetic field oriented perpendicular to the coronal plane, that is, in the anterior-posterior (AP) vector direction.
C. POST-PROCESSING SCHEMES
With respect to ICNIRP's 2 mm × 2 mm × 2 mm averaging approach [2] , Fig. 2 illustrates electric field averaging over a 2-mm cube for 1 mm and 0.5 mm voxels. The volume averaged in situ electric field, E V (r c ), is evaluated as the arithmetic average of the vector electric field strength in the targeted tissue voxels in a 2-mm cube, and then assigned to the center voxel at r c . The volume of the targeted contiguous tissue inside the 2-mm cube is denoted by V 1 , as outlined in thick green polygon in Fig. 2 (b) . A factor, p, that represents the volume percentage of air/other tissues inside the 2-mm cube is defined as p = 100 ×(V −V 1 )/V , where V = 8 mm 3 . p max is the maximum permissible percentage of air/other tissues in the cube. The averaging within target tissue (r∈ V 1 ) is performed using (2) .
where r c is the location of the cube center, v(r) is the intersected volume of the 2-mm cube with the voxel centered at r(r ∈ V 1 ). The volume-averaging is applied to all voxels each centered in their respective cubes. Note that the averaging is performed only for neighboring voxels within contiguous tissue. As illustrated in Fig. 2 (b) , the two voxels in blue at the lower right corner of the 2-mm cube are not considered within V 1 , even though they belong to the same tissue; however, the connectivity constraint is violated as shown in Fig. 2 (b). The connectivity of voxels is obtained using a three-dimensional two-way labelling method. The IEEE standard [3] does not describe implementation of the 5-mm linear averaging it prescribes, nor does IEEE deal with tissue interfaces. A key reason is that IEEE uses ellipsoids rather than anatomical models for determining magnetic field coupling to tissue sites.
The scheme for evaluating 5-mm linear averaging for a targeted voxel at r c is illustrated in Fig. 3 (a) , in which a 5-mm averaging line is centered at the target voxel at r c , with its direction denoted by (θ, φ) in local spherical coordinates. Similar to the scheme for 2-mm cubic averaging, the ratio of air/other tissues is defined as p = 100×(L −L 1 )/L, where L 1 is the length of the segment within the same tissue (illustrated in dark magenta in Fig. 3 (b) ), and L = 5 mm. The thickness of the 5-mm averaging line is neglected, in consideration of the relatively large model resolution compared with the radius of a nerve axon. The linear averaging is performed using (3) . where l(r) is the length of the intersected segment of the 5-mm line with the voxel centered at r. Fig. 3 (a) shows the 5-mm line intersecting with 5 contiguous voxels within the same tissue (resolution of 2 mm); each segment lengths shown in different colors in Fig. 3 (a) are calculated with the Liang-Barsky algorithm [42] . The directions of the averaging line (θ, φ) vary from 0 • to 180 • in 20 • intervals. Averaging is performed over a total of 81 directions for the targeted voxel at r c . The final averaged value is taken as the maximum value over 81 records.
The relative difference in the averaged electric field between the volume-and line-averaging schemes is expressed as:
where the reference value, E ref , is the mean of E V and E L .
III. COMPUTATIONAL RESULTS
A. MULTI-LAYER SPHERE Fig. 4 shows the distributions of in situ electric field in the cross sections of the spherical model with different resolutions. The highest electric field strengths, as expected, are located at the model surfaces. The field distributions for all three resolutions are generally in good agreement, except for slight differences at the tissue/air and tissue/tissue interfaces. For resolutions of 0.5, 1, and 2 mm, the maximum voxel in situ electric fields in the skin were 1.598, 1.561, and 1.501 mV/m, respectively, while they were 1.447, 1.430, and 1.305 mV/m, respectively, in the grey matter. This tendency is in line with previous findings that the maximum electric field increases with improved model resolution [29] . The values for 0.5 mm resolution are approximately 27% (skin) and 40% (grey matter) larger than the theoretical maxima, 1.256 mV/m for skin, and 1.037 mV/m for grey matter. Both averaging schemes were then applied to the in situ electric field strengths. The top 1% of the averaged field strengths are shown in Fig. 5 . All tissues are represented in Fig. 5 (a) , while skin and grey matter are shown separately in Figs. 5 (b) and (c), respectively (p max = 0% for all). In general, the percentile values of in situ electric field strength (excluding the maxima) are higher in the lowresolution models. This is because the highest electric field strengths are at the surface of the sphere, and thus the lowerresolution sphere has a higher percentage of voxels near the tissue/air interface where artefacts are significant.
B. HUMAN BODY MODELS
The top 1% of the in situ electric field strengths in TARO are shown in Fig. 6 . Fig. 6 (a) includes all tissues, and Figs. 6 (b)-(f) show each tissue individually. It is clear from this figure that both averaging schemes provide comparable results. In general, the higher resolution models have higher electric field strengths, except in the grey and white matter, which contain large areas of folded surfaces. This trend is different from that observed in the spherical model ( Fig. 5) , with the discrepancy attributable to the singularities originating from the complexity of the anatomical configurations of the human-like model. The line-and volume-averaged values are rather stable for different resolutions excluding the top ∼0.1% voxels where computational artefacts could not be suppressed.
The volume-averaged, line-averaged, and voxel in situ electric field strengths on the surface of TARO are shown in Fig. 7 . It is clear from this figure that the field distributions are similar to each other for models with different spatial resolutions. High electric field strengths can be observed around the neck, armpit and crotch regions, as expected.
C. DIFFERENCE BETWEEN TWO AVERAGING SCHEMES
The differences in the percentile values between the two averaging schemes are then investigated in terms of the relative differences defined by (4) . The results are presented in Table 2 for the spherical model and in Table 3 for TARO.
For the spherical models, the relative differences between volume-and line-averaging (d r ) in the top 1% electric field are subtle; for p max = 0%, they are ≤1.4% for the model with a resolution of 0.5 mm, and ≤3.4% for the model with a resolution of 1 mm (not shown). For the anatomical models, the largest relative difference is ∼30% in the grey matter (p max = 20%). If the highest 1% electric fields are excluded, the relative difference decreases to ∼3% for muscle and white matter, and is less than 9% for fat and heart (p max = 0%). Also for grey and white matter of TARO, d r is low when p max = 0%.
In order to clarify the difference between volume-and line-averaged electric fields, their spatial distributions are shown in Fig. 8 . In Fig. 8 (a) and (b), all averaged voxels are compared. It is obvious that the differences between the two averaging schemes mainly exist on the tissue/air and tissue/tissue interfaces. This is because the sets of averaged voxels are different. For example, considering a targeted voxel located near a tissue boundary, a 2-mm cube-averaged field E V (r) might be 0 V/m, but the 5-mm line-averaged field E L (r) might be a non-zero value, and vice versa. In particular, the 2-mm cubic averaging excludes more voxels than the 5-mm linear averaging does. Also, tissues like the skin and retina are too thin to cover the whole 2 mm × 2 mm × 2 mm averaging volume, while the averaging line can be orientated such that the segment is still located within the same tissue. Marginal differences for both schemes can be observed from FIGURE 7. Distributions of in situ electric field strength in TARO for uniform magnetic field exposure. Voxel field distributions are shown in (a), (b), and (c) for TARO with resolution of 2 mm, 1 mm, and 0.5 mm, respectively; volume-averaged field distributions are shown in (d) and (e) for TARO with resolution of 1 mm, and 0.5 mm, respectively; line-averaged field distributions are shown in (f) and (g) for TARO with resolution of 1 mm, and 0.5 mm, respectively. Maximum permissible percentage for air/other tissues inclusion is p max = 0%. Fig. 8 (c) and (d) , where only the averaged voxels in common for the two schemes are included.
D. AIR/OTHER TISSUES INCLUSION IN AVERAGING
With 2-mm cubic and 5-mm linear averaging, outermost layers of voxels of specific tissues are excluded from averaging, with more voxels excluded with finer resolution. We then investigated the in situ electric fields for different percentages of air/other tissues inclusion in the cube and line for post-processing. Figs. 9 and 10 show the in-situ electric field strengths for different p max values for the sphere and TARO, respectively. A value of p max = 0% produces the lowest averaged in situ electric field. As p max increases in steps of 10%, the percentile values increase toward the curves for voxel field strengths, and the relative differences between the two averaging are insignificant for the sphere and tend to decrease for TARO ( Table 3 ). In general, with p max set to >20-30%, reproducible results can be expected for TARO (Fig. 10) . In contrast, the line-averaging appears more sensitive to p max . This can be seen from the percentile values for the heart, where almost equally spaced curves are observed across p max .
For relatively thin tissues such as skin, if p max = 0%, then all skin voxels are excluded from the cubic averaging. As seen from Fig. 10 , p max ≈ 30% is required for 2-mm cubic averaging to generate stable percentile values (bottom curve).
In contrast, 5-mm linear averaging is still reproducible even for thin tissue like the skin. Table 4 and Table 5 summarize the calculated percentile values of the in situ electric fields in selected tissues for different sizes of averaging cubes for the sphere and for TARO, respectively, with 0.5 mm voxels and p max = 30%. In general, for both models the averaged electric field strength decreases with cube size (except for skin in TARO). Specifically, the ratio of the maximum electric field strength averaged over 1-mm cube to that averaged over 3-mm cube is about 1.1, and 2, for the sphere and TARO, respectively, but for both models, the 99 th to 99.99 th percentile values are less dependent on the averaging volume.
E. EFFECT OF THE AVERAGING CUBE SIZE
For the spherical model, the relative differences between numerical and theoretical percentile values decrease slightly with the increased cubic size. Also, for the 99 th to 99.99 th results for TARO. Specifically, the 99 th to 99.99 th percentile values for grey matter and heart are fairly stable for different sizes of the cubes. Relatively large variability can be found in skin even for the 99 th percentile values. This is because a larger averaging cube tends to exclude more skin voxels with a given p max .
F. INCLUSION OF SUBCUTANEOUS TISSUE IN VOLUME-AVERAGING FOR SKIN
For thin tissues like skin, the ICNIRP guideline (2010) suggests that the averaging volume ''may extend to subcutaneous tissue'' [2] . Inclusion of subcutaneous tissue in volume averaging for the skin was factored into this study by redefining V 1 in (2) as the volume of non-air voxels in a 2-mm cube. Consequently, for this case, the ratio p max is redefined as the maximum permissible air inside the cube.
Figs. 11(a) and (b) show the calculated percentile in situ electric fields for the skin of the TARO models with a resolution of 1 mm and 0.5 mm, respectively. As can be seen, for p max > 10%, the percentile values are clearly more stable than previously calculated (see Table 4 ). If no air voxels are allowed in the averaging cube (i.e. p max > 0%), large variations are still observed.
IV. DISCUSSION AND CONCLUDING REMARKS
This study developed methods for implementing 2-mm cubic and 5-mm linear averaging of electric fields induced in tissue by magnetic fields as prescribed, respectively, by ICNIRP and IEEE. The ICNIRP guideline states, ''the 2 × 2 × 2 mm 3 averaging volume should not extend beyond the boundary of the tissue except for tissues such as the retina and skin, which are too thin to cover the whole averaging cube.'' Aside from this stipulation, neither guideline provides further guidance as to specific dosimetric procedures for assessing compliance with the BR or DRL. The analyses presented here compare the induced in situ electric fields between the two averaging schemes over different voxel resolutions when the computational boundaries fall entirely within the specific target tissue (Fig. 6 ), and when spatial averaging is extended to computational boundaries that span a tissue/tissue or tissue/air interface (Fig. 10) .
This paper first adopted the spherical model as a convenient way to demonstrate ''proof of concept'' concerning tissue inclusion, but given its shape regularity, its results do not represent the variability seen in the anatomical modeling across p max (Tables 2 and 3 ) and cube size (Tables 4 and 5) .
A previous study of dose to brain tissue from transcranial magnetic stimulation reported good agreement between the median in situ electric fields and corresponding 95% confidence intervals for both the 2-mm cubic and 5-mm linear averages of in situ electric fields [43] . The study in this paper reports a similar tendency (Table 3) for the ≤ 99.99 th percentile of inner tissues, with relatively large differences for maximum values (100 th percentile). These latter differences occur at voxels located at tissue boundaries as well as at skinto-skin contact regions where stair-casing errors are not easily excluded by spatial averaging alone [32] , [44] . Although cubic and linear averaging probably relate to different in situ electric field interactions, the dosimetry results indicate that their percentile in situ electric fields are not radically different from one another. Thus, neither scheme is likely to cause a significant difference between ICNIRP and IEEE with respect to dose estimation. Differences across populations -size, shape, tissue mix, etc. -and exposure scenario will probably produce more variability than the respective algorithms.
For all but muscle, the anatomical model results (Table 3) show slightly lower electric fields for linear than for cubic averaging. The reason is that the larger stencil dimension (the long dimension of the averaging line/volume, i.e., 5 mm vs. 2 mm) results in the tendency of the linear method's spatial filtering to yield lower electric field values, compared to cubic averaging. Below the 99 th percentile, the 2-mm cubic and 5-mm linear averaged in situ electric fields were comparable (data not shown). A recent study [33] suggested that 99.99 th percentile is a computationally stable metric for the same model using different numerical methods. Nonetheless, only limited data are available with which to recommend an optimal percentile estimate of maximum dose to tissue from magnetic field exposure.
Restricting the averaging computations to only those cubic volumes or linear segments completely within a tissue will very often lead to the exclusion of voxels located at the tissue boundaries. Consequently, both artefacts and actual physical fields are excluded by post-processing, and furthermore, more voxels are excluded with higher resolution models. Our results suggest that a percentage of air/other tissues may be included in post-processing as a practical compromise, accounting for more tissue and permitting higher resolutions, recognizing, however, that the additional anatomical volume or linear segment beyond the tissue boundary may not relate to the biological effect of interest (synaptic activity alteration or PNS). The results indicate that 2-mm cubic averaging provides stable post-processing percentiles with a ∼20% to ∼30% inclusion criterion for inner tissues. In contrast, 5-mm linear averaging is more sensitive to p max (Fig. 10) .
For cubic averaging in skin, a large variation of calculated in situ electric fields occurs if no air/other tissues are allowed in the computational volume ( Fig. 10 ). As indicated in Results, ICNIRP permits extending into subcutaneous tissue when averaging for skin [2] . This is based on recognizing both skin and fat as surrogates for PNS, even without rigorous validation [45] . We suggest (subsection III.F) that for skin, at least ∼10% air inclusion is necessary for reproducibly averaged electric fields with different voxel resolutions, even when subcutaneous tissues are also included in the averaging (Fig. 11 ).
To recommend appropriate percentile values for in situ electric fields with the averaging schemes considered here will require further study. ROBERT Executive. His career at EPRI was committed to managing, designing, and participating in EMF health and safety research spanning the nonionizing spectrum from direct current (DC) through power frequencies to radio frequencies (RF). He is currently with the Harvard T. H. Chan School of Public Health, Boston, as a Visiting Scientist. He was involved intimately with studies that included the areas of epidemiology, exposure assessment, laboratory studies (in vivo and in vitro), dosimetry, instrumentation, and the development of modeling software. These studies covered key health and safety endpoints including cancer and pregnancy outcome, and the basis for exposure limits as published by the International Commission on Non-Ionizing Radiation Protection and IEEE. He has authored or coauthored about 100 peer-reviewed publications concerned with the above-mentioned EMF topics. Dr. Kavet is currently serving as a Co-Chair of subcommittee three of IEEE's International Committee on Electromagnetic Safety (ICES) concerned with establishing exposure standards for frequencies between 0 and 5 MHz. 
